The novel coronavirus, Covid-19, has rapidly spread around the world, overwhelming healthcare systems, shutting down countries and causing widespread grocery shortages. Understandably, this has led to fear and misinformation about the Covid-19 virus and potential treatment options.
The Industry is Ready to Take on This Challenge
- GSK is collaborating on two separate Covid-19 vaccines with the University of Queensland in Australia and Chinese pharmaceutical company, Clover.
- Moderna is collaborating with the National Institute of Allergy and Infectious Diseases (NIAID) on their mRNA vaccine.
- AbbVie is working with the WHO, CDC and National Institutes of Health to repurpose their antiviral combination lopinavir/ritonavir.
- The U.S Biomedical Advanced Research and Development Authority (BARDA) is working with pharma companies, including Johnson & Johnson and Sanofi.